Meloxoral

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 04/10/2021

Authorisation details

Product details
Name
Meloxoral
Agency product number
EMEA/V/C/000151
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Dechra Regulatory B.V.
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
19/11/2010
Contact address

Handelsweg 25
5531 AE Bladel
The Netherlands

Product information

01/10/2021 Meloxoral - EMEA/V/C/000151 - IG/1444

This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Musculo-skeletal system

  • Anti-inflammatory and anti-rheumatic products, non-steroids

Therapeutic indication

Cats

Alleviation of inflammation and pain in chronic musculoskeletal disorders.

Dogs

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Assessment history

Related content

How useful was this page?

Add your rating